3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
One document
more
Stories about Biosimilar
- Language:
- Media:
- Period:
- Period:Total
Press release: STADA continues strong growth journey in the first half of 2024
One documentmorePress release: STADA continues with double-digit sales and profit growth in 2023
One documentmoreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
more
1